| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 39 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 38 |
| 2 | TACROLIMUS OINTMENT 0.1% | 38 |
| 3 | MYCOPHENOLATE MOFETIL | 16 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 16 |
| 5 | PREDNISONE | 15 |
| 6 | SIROLIMUS | 12 |
| 7 | PREDNISOLONE | 10 |
| 8 | PREDNISOLONE ORAL | 10 |
| 9 | PREDNISOLONE ORAL SOLUTION | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 5 | 0.0018 |
| 1 | BELATACEPT | 7 | 0.0015 |
| 2 | MARIBAVIR | 3 | 0.0012 |
| 3 | SIROLIMUS | 12 | 0.0009 |
| 4 | DARUNAVIR 600 MG | 5 | 0.0008 |
| 5 | GANCICLOVIR SODIUM | 7 | 0.0007 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 | 0.0006 |
| 7 | THIOTEPA | 5 | 0.0005 |
| 8 | RITONAVIR 100 MG | 5 | 0.0003 |
| 9 | DARUNAVIR | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 7 | 0.0015 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 3 | 0.0012 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 4 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Nucleoside Analog Antiviral [EPC] | 7 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 5 | 0.0001 |